Developing Growth Fund
Daily price w/o sales charge as of 01/14/2025
$22.46
$0.13
YTD Returns w/o sales charge as of 01/14/2025
0.22%
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 12/31/2024
- Total Net Assets
- $2.35 B
- Inception Date
- 10/10/1973
- Dividend Frequency
- Annually
- Fund Gross Expense Ratio
- 0.94%
- Fund Net Expense Ratio
- 0.94%
- Number of Holdings
- 81
- Minimum Initial Investment
- $1,000+
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 21.89% | 21.89% | -5.45% | 7.26% | 8.53% | 10.47% |
| Lipper Category Avg. Small-Cap Growth Funds | 14.73% | 14.73% | -1.44% | 8.05% | 9.12% | - |
| Russell 2000® Growth Index | 15.15% | 15.15% | 0.21% | 6.86% | 8.09% | - |
| w/ sales charge | 14.89% | 14.89% | -7.30% | 6.00% | 7.89% | 10.34% |
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 21.89% | 21.89% | -5.45% | 7.26% | 8.53% | 10.47% |
| Lipper Category Avg. Small-Cap Growth Funds | 14.73% | 14.73% | -1.44% | 8.05% | 9.12% | - |
| Russell 2000® Growth Index | 15.15% | 15.15% | 0.21% | 6.86% | 8.09% | - |
| w/ sales charge | 14.89% | 14.89% | -7.30% | 6.00% | 7.89% | 10.34% |
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 12/31/2024View Portfolio
| Holding | Assets |
|---|---|
| Credo Technology Group Holding Ltd | 2.5% |
| Glaukos Corp | 2.5% |
| Reddit Inc | 2.4% |
| CyberArk Software Ltd | 2.3% |
| Astera Labs Inc | 2.3% |
| Agilysys Inc | 2.3% |
| Piper Sandler Cos | 2.0% |
| FTAI Aviation Ltd | 2.0% |
| Comfort Systems USA Inc | 1.9% |
| Cava Group Inc | 1.9% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 12/31/2024View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 21.89% | 21.89% | -5.45% | 7.26% | 8.53% | 10.47% |
| Lipper Category Avg. Small-Cap Growth Funds | 14.73% | 14.73% | -1.44% | 8.05% | 9.12% | - |
| Russell 2000® Growth Index | 15.15% | 15.15% | 0.21% | 6.86% | 8.09% | - |
| w/ sales charge | 14.89% | 14.89% | -7.30% | 6.00% | 7.89% | 10.34% |
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 21.89% | 21.89% | -5.45% | 7.26% | 8.53% | 10.47% |
| Lipper Category Avg. Small-Cap Growth Funds | 14.73% | 14.73% | -1.44% | 8.05% | 9.12% | - |
| Russell 2000® Growth Index | 15.15% | 15.15% | 0.21% | 6.86% | 8.09% | - |
| w/ sales charge | 14.89% | 14.89% | -7.30% | 6.00% | 7.89% | 10.34% |
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
| Year | Fund Returns | Russell 2000® Growth Index |
|---|
| 2024 | 21.89% | 15.15% |
| 2023 | 8.50% | 18.66% |
| 2022 | -36.09% | -26.36% |
| 2021 | -2.66% | 2.83% |
| 2020 | 72.57% | 34.63% |
| 2019 | 31.91% | 28.48% |
| 2018 | 5.09% | -9.31% |
| 2017 | 29.92% | 22.17% |
| 2016 | -2.71% | 11.32% |
| 2015 | -8.90% | -1.38% |
| 2014 | 3.25% | - |
| 2013 | 57.19% | - |
| 2012 | 10.39% | - |
| 2011 | -1.66% | - |
| 2010 | 36.54% | - |
| 2009 | 47.03% | - |
| 2008 | -47.50% | - |
| 2007 | 35.83% | - |
| 2006 | 12.45% | - |
| 2005 | 11.87% | - |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|
| 2025 | - | - | - | - |
| 2024 | 12.62% | 0.92% | 6.32% | 0.88% |
| 2023 | 8.32% | 3.27% | -12.97% | 11.45% |
| 2022 | -19.27% | -21.16% | 0.59% | -0.18% |
| 2021 | 1.64% | 2.87% | -3.66% | -3.35% |
| 2020 | -16.91% | 40.59% | 15.92% | 27.45% |
| 2019 | 27.01% | 9.09% | -11.35% | 7.39% |
| 2018 | 7.16% | 14.97% | 12.18% | -23.96% |
| 2017 | 8.36% | 4.06% | 7.07% | 7.61% |
| 2016 | -10.30% | 2.24% | 10.87% | -4.32% |
| 2015 | 7.12% | 2.61% | -15.70% | -1.68% |
| 2014 | 1.67% | 0.15% | -5.75% | 7.59% |
| 2013 | 13.50% | 10.00% | 18.78% | 6.00% |
| 2012 | 12.16% | -2.68% | 5.55% | -4.19% |
| 2011 | 10.23% | 1.49% | -20.86% | 11.06% |
| 2010 | 8.21% | -7.94% | 16.47% | 17.68% |
| 2009 | -2.17% | 24.37% | 14.25% | 5.76% |
| 2008 | -21.82% | 6.65% | -11.81% | -28.60% |
| 2007 | 4.65% | 13.60% | 9.82% | 4.04% |
| 2006 | 15.98% | -6.23% | -6.80% | 10.93% |
| 2005 | -5.91% | 5.82% | 9.60% | 2.52% |
| 2004 | 2.00% | 0.20% | -7.05% | 11.58% |
| 2003 | -3.27% | 21.33% | 9.79% | 8.70% |
| 2002 | 0.07% | -11.90% | -23.81% | 4.90% |
| 2001 | -17.44% | 16.01% | -22.68% | 25.62% |
| 2000 | 3.52% | -13.67% | -0.56% | -7.37% |
| 1999 | 1.42% | 11.69% | -3.37% | 26.23% |
| 1998 | 11.49% | -2.94% | -22.00% | 28.29% |
| 1997 | -2.88% | 17.68% | 21.77% | -6.03% |
| 1996 | 8.18% | 8.18% | -2.85% | 7.46% |
| 1995 | 6.04% | 19.02% | 15.90% | -0.42% |
| 1994 | 0.16% | -8.07% | 10.54% | 4.34% |
| 1993 | -0.67% | 1.03% | 8.15% | 3.76% |
| 1992 | -2.92% | -13.34% | 5.39% | 9.32% |
| 1991 | 29.96% | -5.07% | 9.77% | 15.46% |
| 1990 | 1.18% | 11.38% | -24.62% | 10.17% |
| 1989 | 3.04% | 1.70% | 8.07% | 0.77% |
| 1988 | 8.71% | 2.49% | -4.04% | -3.23% |
| 1987 | 23.22% | -1.54% | 5.33% | -21.15% |
| 1986 | 12.02% | 1.82% | -18.44% | 7.95% |
| 1985 | 9.91% | -2.42% | -9.28% | 18.16% |
| 1984 | -15.56% | -5.27% | 1.63% | -4.54% |
| 1983 | 19.37% | 16.69% | -4.44% | -6.33% |
| 1982 | -11.29% | 1.28% | 11.66% | 29.18% |
| 1981 | 6.38% | 7.72% | -18.09% | 14.79% |
| 1980 | -8.32% | 13.37% | 24.22% | 5.17% |
| 1979 | 11.23% | 3.38% | 10.21% | 1.23% |
| 1978 | 12.74% | 18.50% | 11.85% | -9.31% |
| 1977 | -5.21% | 6.36% | 3.99% | 7.90% |
| 1976 | 25.90% | -5.36% | -5.21% | 5.87% |
| 1975 | 36.09% | 17.79% | -12.76% | -0.65% |
| 1974 | 2.02% | -14.31% | -23.96% | -3.25% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 12/31/2024
The chart begins on the Fund's inception date of 10/10/1973.
Based on a hypothetical Class A share investment of $10,000 on 10/10/1973 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Credo Technology Group Holding Ltd | Information Technology | 2.5% |
| Glaukos Corp | Health Care | 2.5% |
| Reddit Inc | Communication Services | 2.4% |
| CyberArk Software Ltd | Information Technology | 2.3% |
| Astera Labs Inc | Information Technology | 2.3% |
| Agilysys Inc | Information Technology | 2.3% |
| Piper Sandler Cos | Financials | 2.0% |
| FTAI Aviation Ltd | Industrials | 2.0% |
| Comfort Systems USA Inc | Industrials | 1.9% |
| Cava Group Inc | Consumer Discretionary | 1.9% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| FTAI Aviation Ltd | Industrials | 2.4% |
| Cava Group Inc | Consumer Discretionary | 2.4% |
| Piper Sandler Cos | Financials | 2.3% |
| Reddit Inc | Communication Services | 2.3% |
| CyberArk Software Ltd | Information Technology | 2.2% |
| Comfort Systems USA Inc | Industrials | 2.2% |
| Glaukos Corp | Health Care | 2.2% |
| Wix.com Ltd | Information Technology | 2.2% |
| Agilysys Inc | Information Technology | 2.1% |
| Sweetgreen Inc | Consumer Discretionary | 2.1% |
| Loar Holdings Inc | Industrials | 2.1% |
| Credo Technology Group Holding Ltd | Information Technology | 2.0% |
| Natera Inc | Health Care | 1.9% |
| Hamilton Lane Inc | Financials | 1.9% |
| Modine Manufacturing Co | Consumer Discretionary | 1.8% |
| Evercore Inc | Financials | 1.8% |
| Intra-Cellular Therapies Inc | Health Care | 1.7% |
| MakeMyTrip Ltd | Consumer Discretionary | 1.7% |
| Arcellx Inc | Health Care | 1.7% |
| Guidewire Software Inc | Information Technology | 1.7% |
| Q2 Holdings Inc | Information Technology | 1.7% |
| Astera Labs Inc | Information Technology | 1.6% |
| Vertex Inc | Information Technology | 1.6% |
| Varonis Systems Inc | Information Technology | 1.6% |
| Insmed Inc | Health Care | 1.6% |
| Freshpet Inc | Consumer Staples | 1.4% |
| Parsons Corp | Industrials | 1.4% |
| REVOLUTION Medicines Inc | Health Care | 1.4% |
| Crane Co | Industrials | 1.4% |
| Sterling Infrastructure Inc | Industrials | 1.4% |
| Itron Inc | Information Technology | 1.4% |
| Moog Inc | Industrials | 1.3% |
| Monday.com Ltd | Information Technology | 1.3% |
| ADMA Biologics Inc | Health Care | 1.3% |
| AeroVironment Inc | Industrials | 1.3% |
| PROCEPT BioRobotics Corp | Health Care | 1.3% |
| Impinj Inc | Information Technology | 1.2% |
| Life Time Group Holdings Inc | Consumer Discretionary | 1.1% |
| SpringWorks Therapeutics Inc | Health Care | 1.1% |
| SPX Technologies Inc | Industrials | 1.1% |
| AAON Inc | Industrials | 1.1% |
| Descartes Systems Group Inc/The | Information Technology | 1.1% |
| MACOM Technology Solutions Holdings Inc | Information Technology | 1.1% |
| Krystal Biotech Inc | Health Care | 1.1% |
| Doximity Inc | Health Care | 1.0% |
| Blueprint Medicines Corp | Health Care | 1.0% |
| Sprouts Farmers Market Inc | Consumer Staples | 1.0% |
| Duolingo Inc | Consumer Discretionary | 0.9% |
| Crinetics Pharmaceuticals Inc | Health Care | 0.9% |
| Stride Inc | Consumer Discretionary | 0.9% |
| Intapp Inc | Information Technology | 0.9% |
| Maplebear Inc | Consumer Staples | 0.9% |
| Tarsus Pharmaceuticals Inc | Health Care | 0.9% |
| Primo Brands Corp | Consumer Staples | 0.9% |
| Nuvalent Inc | Health Care | 0.8% |
| Fabrinet | Information Technology | 0.8% |
| Zeta Global Holdings Corp | Information Technology | 0.8% |
| Dutch Bros Inc | Consumer Discretionary | 0.8% |
| Clear Secure Inc | Information Technology | 0.8% |
| Mirion Technologies Inc | Information Technology | 0.8% |
| GeneDx Holdings Corp | Health Care | 0.8% |
| Kratos Defense & Security Solutions Inc | Industrials | 0.8% |
| Core Scientific Inc | Information Technology | 0.8% |
| RxSight Inc | Health Care | 0.8% |
| Merus NV | Health Care | 0.8% |
| Shake Shack Inc | Consumer Discretionary | 0.7% |
| Clearwater Analytics Holdings Inc | Information Technology | 0.7% |
| Vaxcyte Inc | Health Care | 0.7% |
| Ollie's Bargain Outlet Holdings Inc | Consumer Discretionary | 0.7% |
| Avidity Biosciences Inc | Health Care | 0.7% |
| Primoris Services Corp | Industrials | 0.6% |
| Vital Farms Inc | Consumer Staples | 0.6% |
| Janux Therapeutics Inc | Health Care | 0.6% |
| Mirum Pharmaceuticals Inc | Health Care | 0.6% |
| Vera Therapeutics Inc | Health Care | 0.5% |
| Madrigal Pharmaceuticals Inc | Health Care | 0.5% |
| Klaviyo Inc | Information Technology | 0.5% |
| Universal Technical Institute Inc | Consumer Discretionary | 0.3% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 12/31/2024
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
0.6%
|
|
| Real Estate | 0.0% | |
| Utilities | 0.0% | |
| Consumer Discretionary |
0.5%
|
|
| Consumer Staples |
0.4%
|
|
| Energy | 0.0% | |
| Financials |
 0.7%
|
|
| Health Care |
2.7%
|
|
| Industrials |
0.4%
|
|
| Information Technology |
1.1%
|
|
| Materials | 0.0% |
Portfolio Details as of 12/31/2024
- Total Net Assets
- $2.35 B
- Number of Holdings
- 81
- Weighted Average Market Cap.
- 8.7 B
- P/B Ratio
- 7.5x
- P/E Ratio
- 46.4x
To view definitions for the above Portfolio Details, Click here.
Market Capitalization Breakdown - Morningstar separates stock portfolio holdings into five market-capitalization groups: Giant, Large, Mid, Small, and Micro. Of the 5000 largest domestic stocks in their equities database, the top 1% are categorized as Giant, the next 4% are Large, the next 15% are Mid, the next 30% are Small, and the remaining 50% are Micro. Stocks outside of the largest 5000 are also classified as Micro.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Portfolio Turnover - This is a measure of the Fund’s trading activity which is computed by taking the lesser of purchases or sales divided by average monthly market value, excluding short-term investments. The resulting percentage represents the percentage of the portfolio’s holdings that have changed over the past year.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 01/14/2025
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 11/25/2024 | 11/26/2024 | 11/26/2024 | $0.00570 | $24.23 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 12/01/2025 | 12/02/2025 | 12/02/2025 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/22/2021 | 11/23/2021 | $3.3406 | - | $3.3406 | $27.44 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 01/14/2025
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $23.83 |
| $50,000 to $99,999 | 4.75% | 4.00% | $23.58 |
| $100,000 to $249,999 | 3.95% | 3.25% | $23.38 |
| $250,000 to $499,999 | 2.75% | 2.25% | $23.10 |
| $500,000 to $999,999 | 1.95% | 1.75% | $22.91 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $22.46 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 12/31/2024
| Fund Gross Expense Ratio | 0.94% |
| Fund Net Expense Ratio | 0.94% |
Fund Documents
Fund Documents
|
0Documents selected
|
||||
|---|---|---|---|---|
|
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
|
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
||||
|
Statutory Prospectus
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
||||
|
Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
Semi-Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
Fact Sheet
Publish Date:11/03/2015
|
||||
|
Commentary
Publish Date:11/03/2015
|
||||
|
Fund Story
Publish Date:11/03/2015
|